Abstract
Background: The ability of bacteria to form biofilm is an essential strategy for creating stable infections. This issue is more critical in Acinetobacter bauamannii as a hospital pathogen. Today, the control of biofilm formation and solutions to prevent or remove biofilm is being developed. Carvacrol has been considered an anti-biofilm compound in significant bacteria. This study investigated the anti-biofilm effect of Carvacrol on biofilm formation in clinical colistin heteroresistant isolates of A. baumannii.
Methods: 22 clinical strains of A. baumannii were collected from Motahari Hospital in Tehran, Iran, in 2019. Biochemical and genotypic methods confirmed these isolates. Colistin heteroresistance was determined by the Standard PAP method. Carvacrol's antibacterial and anti-biofilm activity was determined according to the standard protocol.
Results: About 12 isolates were considered strong biofilm producers and were used for analysis. Six isolates had hetero-resistance to colistin. Carvacrol at a 512 g/ml concentration showed the best antibacterial activity against all isolates. The sub-MIC of Carvacrol (256 g/ml) reduced the biofilm formation capacity, which was statistically significant (p < 0.05).
Conclusion: The results of this study showed that sub-MIC of Carvacrol has anti-biofilm effects in clinical A.baumannii colistin hetero-resistance isolates.
Graphical Abstract
[1]
Kumar S, Anwer R, Azzi A. Virulence potential and treatment options of multidrug-resistant (MDR) Acinetobacter baumannii. Microorganisms 2021; 9(10): 2104.
[http://dx.doi.org/10.3390/microorganisms9102104] [PMID: 34683425]
[http://dx.doi.org/10.3390/microorganisms9102104] [PMID: 34683425]
[2]
(a) Gedefie A, Demsiss W, Belete MA, et al. Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: A review. Infect Drug Resist 2021; 14: 3711-9.
[http://dx.doi.org/10.2147/IDR.S332051] [PMID: 34531666];
(b) Yasemi M, Peyman H, Asadollahi K, et al. Frequency of bacteria causing urinary tract infections and their antimicrobial resistance patterns among pediatric patients in Western Iran from 2007-2009. J Biol Regul Homeost Agents 2014; 28(3): 443-8.
[PMID: 25316131];
(c) Narimisa N, Amraei F, Kalani BS, Azarnezhad A, Jazi FM. Biofilm establishment, biofilm persister cell formation, and relative gene expression analysis of type II toxin-antitoxin system in Klebsiella pneumoniae. Gene Rep 2020; 21: 100846.
[http://dx.doi.org/10.1016/j.genrep.2020.100846];
(d) Shivaee A, Mohammadzadeh R, Shahbazi S, Pardakhtchi E, Ohadi E, Kalani BS. Time-variable expression levels of mazF, atlE, sdrH, and bap genes during biofilm formation in Staphylococcus epidermidis. Acta Microbiol Immunol Hung 2019; 66(4): 499-508.
[http://dx.doi.org/10.1556/030.66.2019.019] [PMID: 31198057];
(e) Shivaee A, Sadeghi Kalani B, Talebi M, Darban-Sarokhalil D. Does biofilm formation have different pathways in Staphylococcus aureus? Iran J Basic Med Sci 2019; 22(10): 1147-52.
[PMID: 31998455]
[http://dx.doi.org/10.2147/IDR.S332051] [PMID: 34531666];
(b) Yasemi M, Peyman H, Asadollahi K, et al. Frequency of bacteria causing urinary tract infections and their antimicrobial resistance patterns among pediatric patients in Western Iran from 2007-2009. J Biol Regul Homeost Agents 2014; 28(3): 443-8.
[PMID: 25316131];
(c) Narimisa N, Amraei F, Kalani BS, Azarnezhad A, Jazi FM. Biofilm establishment, biofilm persister cell formation, and relative gene expression analysis of type II toxin-antitoxin system in Klebsiella pneumoniae. Gene Rep 2020; 21: 100846.
[http://dx.doi.org/10.1016/j.genrep.2020.100846];
(d) Shivaee A, Mohammadzadeh R, Shahbazi S, Pardakhtchi E, Ohadi E, Kalani BS. Time-variable expression levels of mazF, atlE, sdrH, and bap genes during biofilm formation in Staphylococcus epidermidis. Acta Microbiol Immunol Hung 2019; 66(4): 499-508.
[http://dx.doi.org/10.1556/030.66.2019.019] [PMID: 31198057];
(e) Shivaee A, Sadeghi Kalani B, Talebi M, Darban-Sarokhalil D. Does biofilm formation have different pathways in Staphylococcus aureus? Iran J Basic Med Sci 2019; 22(10): 1147-52.
[PMID: 31998455]
[3]
(a) Sharifi-Rad M, Varoni EM, Iriti M, et al. Carvacrol and human health: A comprehensive review. Phytother Res 2018; 32(9): 1675-87.
[http://dx.doi.org/10.1002/ptr.6103] [PMID: 29744941];
(b) Asadi S, Nayeri-Fasaei B, Zahraei-Salehi T, Yahya-Rayat R, Shams N, Sharifi A. Antibacterial and anti-biofilm properties of carvacrol alone and in combination with cefixime against Escherichia coli. BMC Microbiol 2023; 23(1): 55.
[http://dx.doi.org/10.1186/s12866-023-02797-x] [PMID: 36864390]
[http://dx.doi.org/10.1002/ptr.6103] [PMID: 29744941];
(b) Asadi S, Nayeri-Fasaei B, Zahraei-Salehi T, Yahya-Rayat R, Shams N, Sharifi A. Antibacterial and anti-biofilm properties of carvacrol alone and in combination with cefixime against Escherichia coli. BMC Microbiol 2023; 23(1): 55.
[http://dx.doi.org/10.1186/s12866-023-02797-x] [PMID: 36864390]
[4]
(a) Wijesundara NM, Lee SF, Cheng Z, Davidson R, Rupasinghe HPV. Carvacrol exhibits rapid bactericidal activity against Streptococcus pyogenes through cell membrane damage. Sci Rep 2021; 11(1): 1487.
[http://dx.doi.org/10.1038/s41598-020-79713-0] [PMID: 33452275];
(b) Can Baser K. Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr Pharm Des 2008; 14(29): 3106-19.
[http://dx.doi.org/10.2174/138161208786404227] [PMID: 19075694]
[http://dx.doi.org/10.1038/s41598-020-79713-0] [PMID: 33452275];
(b) Can Baser K. Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr Pharm Des 2008; 14(29): 3106-19.
[http://dx.doi.org/10.2174/138161208786404227] [PMID: 19075694]
[5]
Rathod NB, Kulawik P, Ozogul F, Regenstein JM, Ozogul Y. Biological activity of plant-based carvacrol and thymol and their impact on human health and food quality. Trends Food Sci Technol 2021; 116: 733-48.
[http://dx.doi.org/10.1016/j.tifs.2021.08.023]
[http://dx.doi.org/10.1016/j.tifs.2021.08.023]
[6]
Karakonstantis S, Saridakis I. Colistin heteroresistance in acinetobacter spp.: Systematic review and meta-analysis of the prevalence and discussion of the mechanisms and potential therapeutic implications. Int J Antimicrob Agents 2020; 56(2): 106065.
[http://dx.doi.org/10.1016/j.ijantimicag.2020.106065] [PMID: 32599229]
[http://dx.doi.org/10.1016/j.ijantimicag.2020.106065] [PMID: 32599229]
[7]
(a) Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 2006; 44(8): 2974-6.
[http://dx.doi.org/10.1128/JCM.01021-06] [PMID: 16891520];
(b) Hematian A, Goudarzi H, Ghalavand Z, et al. The relationship between phoH and colistin-heteroresistant in clinical isolates of Acinetobacter baumannii. Gene Rep 2021; 25: 101356.
[http://dx.doi.org/10.1016/j.genrep.2021.101356]
[http://dx.doi.org/10.1128/JCM.01021-06] [PMID: 16891520];
(b) Hematian A, Goudarzi H, Ghalavand Z, et al. The relationship between phoH and colistin-heteroresistant in clinical isolates of Acinetobacter baumannii. Gene Rep 2021; 25: 101356.
[http://dx.doi.org/10.1016/j.genrep.2021.101356]
[8]
Ezadi F, Jamali A, Heidari A, Javid N, Ardebili A. Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran. J Glob Antimicrob Resist 2020; 21: 380-5.
[http://dx.doi.org/10.1016/j.jgar.2019.11.010] [PMID: 31770604]
[http://dx.doi.org/10.1016/j.jgar.2019.11.010] [PMID: 31770604]
[9]
Lajhar SA, Brownlie J, Barlow R. Characterization of biofilm-forming capacity and resistance to sanitizers of a range of E. coli O26 pathotypes from clinical cases and cattle in Australia. BMC Microbiol 2018; 18(1): 41.
[http://dx.doi.org/10.1186/s12866-018-1182-z]
[http://dx.doi.org/10.1186/s12866-018-1182-z]
[10]
Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter baumannii. New Microbiol 2014; 37(2): 119-27.
[PMID: 24858639]
[PMID: 24858639]
[11]
(a) Jayathilaka EHTT, Rajapaksha DC, Nikapitiya C, De Zoysa M, Whang I. Antimicrobial and anti-biofilm peptide octominin for controlling multidrug-resistant Acinetobacter baumannii. Int J Mol Sci 2021; 22(10): 5353.
[http://dx.doi.org/10.3390/ijms22105353] [PMID: 34069596];
(b) Yarkarami F, Kazemian H, Sadeghifard N, et al. Inhibitory effects of carvacrol on biofilm formation and expression of biofilm related genes in clinical isolates of Enterococcus faecalis. Clin Lab 2022; 68(06/2022)
[http://dx.doi.org/10.7754/Clin.Lab.2021.210853] [PMID: 35704732]
[http://dx.doi.org/10.3390/ijms22105353] [PMID: 34069596];
(b) Yarkarami F, Kazemian H, Sadeghifard N, et al. Inhibitory effects of carvacrol on biofilm formation and expression of biofilm related genes in clinical isolates of Enterococcus faecalis. Clin Lab 2022; 68(06/2022)
[http://dx.doi.org/10.7754/Clin.Lab.2021.210853] [PMID: 35704732]
[12]
do Nascimento LD, da Costa KS, Cascaes MM, de Aguiar Andrade EH. Encapsulation of essential oils by spray-drying: Antimicrobial activity, and applications in food preservation.Essential Oils: Applications and Trends in Food Science and Technology. Springer 2022; pp. 101-21.
[http://dx.doi.org/10.1007/978-3-030-99476-1_6]
[http://dx.doi.org/10.1007/978-3-030-99476-1_6]
[13]
Cacciatore I, Di Giulio M, Fornasari E, et al. Carvacrol codrugs: A new approach in the antimicrobial plan. PLoS One 2015; 10(4): e0120937.
[http://dx.doi.org/10.1371/journal.pone.0120937] [PMID: 25859852]
[http://dx.doi.org/10.1371/journal.pone.0120937] [PMID: 25859852]
[14]
Nostro A, Marino A, Blanco AR, et al. In vitro activity of carvacrol against staphylococcal preformed biofilm by liquid and vapour contact. J Med Microbiol 2009; 58(6): 791-7.
[http://dx.doi.org/10.1099/jmm.0.009274-0] [PMID: 19429756]
[http://dx.doi.org/10.1099/jmm.0.009274-0] [PMID: 19429756]
[15]
(a) Mirnejad R, Fallahi S, Kiani J, et al. Epidemic assessment of bacterial agents in osteomyelitis and their antibiotic resistance pattern determination. J Biol Sci 2008; 8(2): 478-81.
[http://dx.doi.org/10.3923/jbs.2008.478.481];
(b) Gheysarzadeh A, Sadeghifard N, Safari M, et al. Report of five nurses infected with severe acute respiratory syndrome coronavirus 2 during patient care: Case series. Elsevier 2020; Vol. 36: p. 100694.;
(c) Kenarkoohi A, Bamdad T, Soleimani M, Soleimanjahi H, Fallah A, Falahi S. HSV-TK Expressing mesenchymal stem cells exert inhibitory effect on cervical cancer model. Int J Mol Cell Med 2020; 9(2): 146-54.
[PMID: 32934952]
[http://dx.doi.org/10.3923/jbs.2008.478.481];
(b) Gheysarzadeh A, Sadeghifard N, Safari M, et al. Report of five nurses infected with severe acute respiratory syndrome coronavirus 2 during patient care: Case series. Elsevier 2020; Vol. 36: p. 100694.;
(c) Kenarkoohi A, Bamdad T, Soleimani M, Soleimanjahi H, Fallah A, Falahi S. HSV-TK Expressing mesenchymal stem cells exert inhibitory effect on cervical cancer model. Int J Mol Cell Med 2020; 9(2): 146-54.
[PMID: 32934952]
[16]
Marchese A, Arciola CR, Coppo E, et al. The natural plant compound carvacrol as an antimicrobial and anti-biofilm agent: Mechanisms, synergies and bio-inspired anti-infective materials. Biofouling 2018; 34(6): 630-56.
[http://dx.doi.org/10.1080/08927014.2018.1480756] [PMID: 30067078]
[http://dx.doi.org/10.1080/08927014.2018.1480756] [PMID: 30067078]
